Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Tapio Utriainen
Hypertension as Predictor of Sunitinib Treatment Outcome in Metastatic Renal Cell Carcinoma
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Direct Measurement of the Lumped Constant for 2-Deoxy-[1-14C]glucose in Vivo in Human Skeletal Muscle
American Journal of Physiology - Endocrinology and Metabolism
Endocrinology
Physiology
Metabolism
Diabetes
Related publications
Angiotensin Inhibitors as Treatment of Sunitinib/Pazopanib-Induced Hypertension in Metastatic Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma
Therapeutic Advances in Urology
Urology
Sunitinib-Associated Hypertension and Neutropenia as Efficacy Biomarkers in Metastatic Renal Cell Carcinoma Patients
British Journal of Cancer
Cancer Research
Oncology
Mp16-01 Clinical Implications of Sunitinib and N-Desethyl-Sunitinib Plasma Concentrations for Treatment Outcome in Metastatic Renal Cell Carcinoma Patients
Journal of Urology
Urology
Phase I Trial of Sunitinib and Temsirolimus in Metastatic Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Anlotinib Versus Sunitinib as First‐Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial
Oncologist
Cancer Research
Medicine
Oncology
Long-Term Response to Sunitinib Therapy for Metastatic Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Pcn70 - Assessing the Budget Impact of Including Sunitinib for the Treatment of Metastatic Renal Cell Carcinoma in Argentina
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Survival Benefits of Second-Line Axitinib Versus Everolimus After First Line Sunitinib Treatment in Metastatic Renal Cell Carcinoma
Pathology and Oncology Research
Medicine
Forensic Medicine
Pathology
Oncology
Cancer Research
